As Fatty Liver Spreads, Probiotics Enter the Fray

Guest BloggerClinical Corner

liver

With obesity off the charts, big pharma is racing to bring new drugs to market. Many of the newbie medications tackle the metabolic downsides of obesity: glucose intolerance, high cholesterol and fatty liver. While drugs may be somewhat effective, they can be costly (especially in the United States) and all come with some unhealthy side effect or more. Finding safe … Read More